Welcome to LookChem.com Sign In|Join Free
  • or
[Ru(η61-C6H5(C6H4)NH2)(ethylenediamine)Cl]Cl is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1220106-47-7

Post Buying Request

1220106-47-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1220106-47-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1220106-47-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,0,1,0 and 6 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1220106-47:
(9*1)+(8*2)+(7*2)+(6*0)+(5*1)+(4*0)+(3*6)+(2*4)+(1*7)=77
77 % 10 = 7
So 1220106-47-7 is a valid CAS Registry Number.

1220106-47-7Downstream Products

1220106-47-7Relevant academic research and scientific papers

Control of Reversible Activation Dynamics of [Ru{η6:κ1-C6H5(C6H4)NH2}(XY)]n+ and the Effect of Chelating-Ligand Variation

Martínez-Pe?a, Francisco,Pizarro, Ana M.

, p. 16231 - 16241 (2017)

The potential use of organoruthenium complexes as anticancer drugs is well known. Herein, a family of activatable tethered ruthenium(II) arene complexes of general formula [Ru{η6:κ1-C6H5(C6H4)NH2}(XY)]n+ (closed tether ring) bearing different chelating XY ligands (XY=aliphatic diamine, phenylenediamine, oxalato, bis(phosphino)ethane) is reported. The activation of these complexes (closed- to open-tether conversion) occurs in methanol and DMSO at different rates and to different reaction extents at equilibrium. Most importantly, RuII-complex activation (cleavage of the Ru?Ntether bond) occurs in aqueous solution at high proton concentration (upon Ntether protonation). The activation dynamics can be modulated by rational variation of the XY chelating ligand. The electron-donating capability and steric hindrance of XY have a direct impact on the reactivity of the Ru?N bond, and XY=N,N′-dimethyl-, N,N′-diethyl-, and N,N,N′,N′-tetramethylethylenediamine afford complexes that are more prone to activation. Such activation in acidic media is fully reversible, and proton concentration also governs the deactivation rate, that is, tether-ring closure slows down with decreasing pH. Interaction of a closed-tether complex and its open-tether counterpart with 5′-guanosine monophosphate revealed selectivity of the active (open) complex towards interaction with nucleobases. This work presents ruthenium tether complexes as exceptional pH-dependent switches with potential applications in cancer research.

Controlling the reactivity of ruthenium(II) arene complexes by tether ring-opening

Pizarro, Ana M.,Melchart, Michael,Habtemariam, Abraha,Salassa, Luca,Fabbiani, Francesca P.A.,Parsons, Simon,Sadler, Peter J.

, p. 3310 - 3319 (2010/05/15)

The closed- and open-tethered RuII Carene complexes [Ru II(η6:η1-C6H 5(C6H4)NH2)(en)]Cl2 (2) and [RuII(η6C6H5(C 6H4)NH2)Cl(en)]Cl (3), where en is ethylenedlamine, have been synthesized and their X-ray structures determined. Interconversion between 2 and 3, that Is, tethered-arene ring-closure and ring-opening, in different solvents has been investigated. Complex 2 opens in dimethylsulfoxide (DMSO) by solvent-induced dissociation of the NH2 group of the pendant arm. In methanol, however, equilibrium between 2 and 3 Is reached after 12 h when both species coexist In solution In a ratio of 2:1 (open/closed). In water (pH 7), complete ring closure of 3 to 2 at 298 K occurs in less than 2 h. The tether ring of complex 2 opens at basic pH and closes at neutral pH. Complex 2 opens over time (18 h) in concentrated HCl. The opening-closing process Is fully reversible in the pH range 2-12. Density Functional Theory calculations have been used to obtain insights into the electronic structure of complexes 2 and 3, their UV-vis properties, and their stability compared to their aqua derivatives. Control of tether-ring-opening can contribute toward a strategy for activation and for achieving cytotoxic selectivity of ruthenium arene anticancer drugs.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1220106-47-7